IKEMA: Carfilzomib and dexamethasone plus isatuximab for r/r multiple myeloma

Prof Philippe Moreau speaks to ecancer in an online interview for the virtual EHA 2020 meeting. He discusses the IKEMA trial which looked at carfilzomib and dexamethasone vs carfilzomib and dexamethasone plus isatuximab in relapsed/refractory multiple myeloma. Sign up to…

IKEMA: Carfilzomib and dexamethasone plus isatuximab for r/r multiple myeloma

Source

0
(0)

Prof Philippe Moreau speaks to ecancer in an online interview for the virtual EHA 2020 meeting.

He discusses the IKEMA trial which looked at carfilzomib and dexamethasone vs carfilzomib and dexamethasone plus isatuximab in relapsed/refractory multiple myeloma.

Sign up to ecancer for free to receive tailored email alerts for more videos like this.
ecancer.org/account/register.php

0 / 5. 0

Leave a Reply

Your email address will not be published. Required fields are marked *